Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis.
Publication/Presentation Date
2-1-2020
Abstract
Chondrosarcomas are rare tumors and, historically, investigation of these tumors has been limited to small series and single-institution studies. There have been no studies that evaluated the identification or comparison of differences in prognostic factors between the five known non-conventional chondrosarcoma subtypes (myxoid, juxtacortical, clear-cell, mesenchymal, and dedifferentiated). The purpose of this paper was to determine the demographic, clinical, incidence, and tumor characteristics of all five known non-conventional chondrosarcoma subtypes, determine the 1-, 5-year, and median survival differences between these subtypes, and to determine the demographic and clinical variables that are significant prognostic indicators for each chondrosarcoma subtypes. We retrospectively reviewed the SEER database for all patients with non-conventional chondrosarcoma. χ
Volume
38
Issue
2
First Page
311
Last Page
319
ISSN
1554-527X
Published In/Presented At
Amer, K. M., Munn, M., Congiusta, D., Abraham, J. A., & Basu Mallick, A. (2020). Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 38(2), 311–319. https://doi.org/10.1002/jor.24463
Disciplines
Medicine and Health Sciences
PubMedID
31498474
Department(s)
Hematology-Medical Oncology Division
Document Type
Article